We performed a retrospective cohort study including people diagnosed with diabetes from 2006 to 2015 according to the Korean National Health Insurance Service-National Sample Cohort database, to analyze the changes in the prevalence, screening rate, and treatment patterns for diabetic retinopathy (DR) over 10 years. The proportion of people who underwent fundus screening for DR steadily increased over the past decade. The prevalence of DR increased from 13.4% in 2006 to 15.9% in 2015, while that of proliferative DR steadily decreased from 1.29% in 2006 to 1.16% in 2015. The proportion of patients undergoing retinal photocoagulation constantly decreased. The prevalence of DR increased over the past decade, while its severity seemed to have improved, with a decreased rate of proliferative DR and retinal photocoagulation. A higher proportion of patients underwent ophthalmic screening using fundus examination, but still less than 30% of patients with diabetes underwent comprehensive examination in 2015.

Citations

Citations to this article as recorded by  

• Variations in Electronic Health Record-Based Definitions of Diabetic Retinopathy Cohorts
  Jimmy S. Chen, Ivan A. Copado, Cecilia Vallejos, Fritz Gerald P. Kalaw, Priyanka Soe, Cindy X. Cai, Brian C. Toy, Durga Borkar, Catherine Q. Sun, Jessica G. Shantha, Sally L. Baxter
  Ophthalmology Science.2024; 4(4): 100468.     CrossRef
• Present and future screening programs for diabetic retinopathy: a narrative review
  Andreas Abou Taha, Sebastian Dinesen, Anna Stage Vergmann, Jakob Grauslund
  International Journal of Retina and Vitreous.2024;[Epub]     CrossRef
• Chronic disease management program applied to type 2 diabetes patients and prevention of diabetic complications: a retrospective cohort study using nationwide data
  Min Kyung Hyun, Jang Won Lee, Seung-Hyun Ko
  BMC Public Health.2023;[Epub]     CrossRef
• Visual Acuity Outcomes in Diseases Associated with Reduced Visual Acuity: An Analysis of the National Health Insurance Service Database in Korea
  Sang-Yeob Kim, Byeong-Yeon Moon, Hyun-Gug Cho, Dong-Sik Yu
  International Journal of Environmental Research and Public Health.2022; 19(14): 8689.     CrossRef
• Prevalence of Diabetic Retinopathy in Undiagnosed Diabetic Patients: A Nationwide Population-Based Study
  Han Na Jang, Min Kyong Moon, Bo Kyung Koo
  Diabetes & Metabolism Journal.2022; 46(4): 620.     CrossRef
• Prevalence and Risk Factors of Diabetic Retinopathy in Diabetes People using Korean National Health and Nutrition Examination Survey VII
  Ihn Sook Jeong, Chan Mi Kang
  Journal of Korean Academy of Community Health Nursing.2022; 33(4): 408.     CrossRef
• Time to Reach Target Glycosylated Hemoglobin Is Associated with Long-Term Durable Glycemic Control and Risk of Diabetic Complications in Patients with Newly Diagnosed Type 2 Diabetes Mellitus: A 6-Year Observational Study (Diabetes Metab J 2021;45:368-78)
  Ja Young Jeon
  Diabetes & Metabolism Journal.2021; 45(4): 613.     CrossRef

Citations

Citations to this article as recorded by  

• Effects of newer-generation anti-diabetics on diabetic retinopathy: a critical review
  Dimitrios P. Ntentakis, Victor San Martin Carvalho Correa, Anastasia Maria Ntentaki, Eleni Delavogia, Toshio Narimatsu, Nikolaos E. Efstathiou, Demetrios G. Vavvas
  Graefe's Archive for Clinical and Experimental Ophthalmology.2024; 262(3): 717.     CrossRef
• Incretin‐based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta‐analysis of observational studies
  Samuel Igweokpala, Naheemot Olaoluwa Sule, Antonios Douros, Oriana H. Y. Yu, Kristian B. Filion
  Diabetes, Obesity and Metabolism.2024; 26(2): 721.     CrossRef
• Weight loss, bariatric surgery, and novel antidiabetic drugs effects on diabetic retinopathy: a review
  Alejandro M. Perez, Emily Neag, Jayanth Sridhar, Basil K. Williams
  Current Opinion in Ophthalmology.2024; 35(3): 192.     CrossRef
• Role of Systemic Factors in Improving the Prognosis of Diabetic Retinal Disease and Predicting Response to Diabetic Retinopathy Treatment
  Joe Mellor, Anita Jeyam, Joline W.J. Beulens, Sanjeeb Bhandari, Geoffrey Broadhead, Emily Chew, Ward Fickweiler, Amber van der Heijden, Daniel Gordin, Rafael Simó, Janet Snell-Bergeon, Anniina Tynjälä, Helen Colhoun
  Ophthalmology Science.2024; 4(4): 100494.     CrossRef
• Novel Antidiabetic Drugs and the Risk of Diabetic Retinopathy: A Systematic Review and Meta-Analysis of Randomized Controlled Trials
  Artur Małyszczak, Joanna Przeździecka-Dołyk, Urszula Szydełko-Paśko, Marta Misiuk-Hojło
  Journal of Clinical Medicine.2024; 13(6): 1797.     CrossRef
• Prognostic factors for the development and progression of proliferative diabetic retinopathy in people with diabetic retinopathy
  Jennifer Perais, Ridhi Agarwal, Jennifer R Evans, Emma Loveman, Jill L Colquitt, David Owens, Ruth E Hogg, John G Lawrenson, Yemisi Takwoingi, Noemi Lois
  Cochrane Database of Systematic Reviews.2023;[Epub]     CrossRef
• Rapid Reduction of HbA1c and Early Worsening of Diabetic Retinopathy: A Real-world Population-Based Study in Subjects With Type 2 Diabetes
  Rafael Simó, Josep Franch-Nadal, Bogdan Vlacho, Jordi Real, Ester Amado, Juana Flores, Manel Mata-Cases, Emilio Ortega, Mercedes Rigla, Joan-Anton Vallés, Cristina Hernández, Didac Mauricio
  Diabetes Care.2023; 46(9): 1633.     CrossRef
• Minimum Effective Dose of DPP-4 Inhibitors for Treating Early Stages of Diabetic Retinopathy in an Experimental Model
  Patricia Bogdanov, Hugo Ramos, Marta Valeri, Anna Deàs-Just, Jordi Huerta, Rafael Simó, Cristina Hernández
  Biomedicines.2022; 10(2): 465.     CrossRef
• Glucagon-Like Peptide 1 Receptor Agonists – Potential Game Changers in the Treatment of Glaucoma?
  Zaynab Ahmad Mouhammad, Rupali Vohra, Anna Horwitz, Anna-Sophie Thein, Jens Rovelt, Barbara Cvenkel, Pete A. Williams, Augusto Azuara-Blanco, Miriam Kolko
  Frontiers in Neuroscience.2022;[Epub]     CrossRef
• Transcriptomic Analysis Reveals That Retinal Neuromodulation Is a Relevant Mechanism in the Neuroprotective Effect of Sitagliptin in an Experimental Model of Diabetic Retinopathy
  Hugo Ramos, Patricia Bogdanov, Rafael Simó, Anna Deàs-Just, Cristina Hernández
  International Journal of Molecular Sciences.2022; 24(1): 571.     CrossRef
• The Safety of Pharmacological and Surgical Treatment of Diabetes in Patients with Diabetic Retinopathy—A Review
  Wojciech Matuszewski, Angelika Baranowska-Jurkun, Magdalena Maria Stefanowicz-Rutkowska, Katarzyna Gontarz-Nowak, Ewa Gątarska, Elżbieta Bandurska-Stankiewicz
  Journal of Clinical Medicine.2021; 10(4): 705.     CrossRef
• Effects of Fibrates on Risk of Development of Diabetic Retinopathy in Japanese Working Age Patients with Type 2 Diabetes and Dyslipidemia: a Retrospective Cohort Study
  Hayato Akimoto, Yasuo Takahashi, Satoshi Asai
  YAKUGAKU ZASSHI.2021; 141(5): 761.     CrossRef
• Association between Add-On Dipeptidyl Peptidase-4 Inhibitor Therapy and Diabetic Retinopathy Progression
  Eugene Yu-Chuan Kang, Chunya Kang, Wei-Chi Wu, Chi-Chin Sun, Kuan-Jen Chen, Chi-Chun Lai, Tien-Hsing Chen, Yih-Shiou Hwang
  Journal of Clinical Medicine.2021; 10(13): 2871.     CrossRef
• Understanding molecular upsets in diabetic nephropathy to identify novel targets and treatment opportunities
  Nidhi Raval, Akshant Kumawat, Dnyaneshwar Kalyane, Kiran Kalia, Rakesh K. Tekade
  Drug Discovery Today.2020; 25(5): 862.     CrossRef
• Letter: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
  Jun Sung Moon
  Diabetes & Metabolism Journal.2019; 43(6): 911.     CrossRef
• Response: Dipeptidyl Peptidase-4 Inhibitors versus Other Antidiabetic Drugs Added to Metformin Monotherapy in Diabetic Retinopathy Progression: A Real World-Based Cohort Study (Diabetes Metab J 2019;43:640–8)
  Yoo-Ri Chung, Kyoung Hwa Ha, Kihwang Lee, Dae Jung Kim
  Diabetes & Metabolism Journal.2019; 43(6): 917.     CrossRef